Medtronic : announces clinical studies underway for two additional indications for Hugo™ RAS system in the U.S.

The company is pursuing hernia and gynecology indications along with urology as it progresses plans to bring choice in robotic surgery technology and partnership to the U.S. Medtronic, a global healthcare technology leader, today announced hernia and gynecologic studies are underway in support of planned submissions to the U.S Food and Drug Administration (FDA) for the Hugo™ robotic-assisted surgery (RAS) system. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.